文献速递腹部MR

MRI衍生肝脏表面结节性评分对非酒精性脂肪性肝病肝纤维化无创定量的诊断价值

Diagnostic value of MRI-derived liver surface nodularity score for the non-invasive quantification of hepatic fibrosis in non-alcoholic fatty liver disease.
PubMed 文献 · Eur Radiol · 2020-08-05

研究纳入47例经临床病理诊断的非酒精性脂肪性肝病(NAFLD)患者,评估MRI衍生肝脏表面结节性(LSN)评分对肝纤维化分期的准确性。结果显示LSN评分在不同纤维化分期之间差异显著(p < 0.001),与纤维化分期的相关性较强(ρ = 0.71;p < 0.001);检测显著纤维化(F2-F4)和晚期纤维化(F3-F4)的ROC曲线下面积分别为0.80(95%CI 0.66-0.95)和0.86(95%CI 0.75-0.97),阈值分别为2.23和2.44;检测晚期纤维化的敏感度为81%、特异度为88%。作者认为基于MR的LSN评分是检测NAFLD患者晚期纤维化的有前景的无创客观工具。

要点

  • LSN评分与纤维化分期强相关(ρ = 0.71;p < 0.001),不同分期之间差异显著(p < 0.001)。
  • 检测显著纤维化(F2-F4)的AUC为0.80(95%CI 0.66-0.95),阈值为2.23。
  • 检测晚期纤维化(F3-F4)的AUC为0.86(95%CI 0.75-0.97),阈值为2.44,敏感度81%、特异度88%。

诊断标准与关键数值

  • 检测显著纤维化(F2-F4)的ROC曲线下面积为0.80(95%CI 0.66-0.95),阈值为2.23。
  • 检测晚期纤维化(F3-F4)的ROC曲线下面积为0.86(95%CI 0.75-0.97),阈值为2.44。
  • 检测晚期纤维化的敏感度为81%、特异度为88%。
  • LSN评分与纤维化分期的相关系数ρ = 0.71(p < 0.001)。
  • 不同纤维化分期之间的LSN评分差异显著(p < 0.001)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To assess the accuracy of MRI-derived liver surface nodularity (LSN) score for staging of hepatic fibrosis in patients with non-alcoholic fatty liver disease (NAFLD).

METHODS: Forty-seven patients with clinicopathological diagnosis of NAFLD who underwent 1.5-T liver MRI within 12 months of liver biopsy were included. Axial non-contrast T1-weighted 3D GRE was used for image analysis. LSN of the left lobe was measured using a custom semiautomated software. Histopathologic analysis (F0-F4) served as the reference standard for staging of fibrosis. Mann-Whitney test and Spearman's correlation coefficient were used to compare LSN scores between different stages of fibrosis and to assess the correlation. Diagnostic performance of LSN score for detection of significant (F2-F4) and advanced (F3-F4) fibrosis was assessed by receiver operating characteristics (ROC) curve. p value of less than 0.05 was considered statistically significant different.

RESULTS: Twenty-one subjects had advanced fibrosis. The LSN scores among different stages of fibrosis were significantly different (p < 0.001). The correlation between LSN score and stage of fibrosis was also strong (ρ = 0.71; p < 0.001). The areas under ROC curves for detection of significant and advanced fibrosis were 0.80 (95% CI 0.66-0.95) and 0.86 (95% CI 0.75-0.97), using a threshold of 2.23 and 2.44, respectively. This method showed 81% sensitivity and 88% specificity for detection of advanced fibrosis.

CONCLUSION: MR-based LSN score is a promising non-invasive objective tool for detection of advanced fibrosis in patients with NAFLD.

KEY POINTS: • Liver surface nodularity (LSN) score is a fast retrospective method for precise quantification of nodularity of liver surface. • MR-based LSN score is a promising non-invasive objective tool to accurately detect different stages of fibrosis in patients with non-alcoholic fatty liver disease (NAFLD).

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Catania R, Furlan A, Smith AD, et al. Diagnostic value of MRI-derived liver surface nodularity score for the non-invasive quantification of hepatic fibrosis in non-alcoholic fatty liver disease. Eur Radiol. 2020. PMID: 32757050. doi:10.1007/s00330-020-07114-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。